Correlation Engine 2.0
Clear Search sequence regions

Highly impacting oral and poster presentations wherein new treatment modalities for coronary artery disease, heart failure and other common cardiovascular diseases were presented throughout the AHA Scientific Sessions 2012, including new developments in the area of lipid-modifying therapies that starred one of the high-impact late-breaking clinical trial sessions during the conference. A summary of the most relevant findings among the over 4,000 abstracts presented during the meeting are reported in the following report. Copyright 2013 Prous Science, S.A.U. or its licensors. All rights reserved.


X Rabasseda. A report from the American Heart Association Scientific Sessions 2012 (November 3-7 - Los Angeles, California, USA). Drugs of today (Barcelona, Spain : 1998). 2013 Jan;49(1):69-84

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 23362495

View Full Text